Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
Novavax's (NVAX) shares continue to soar thanks to the recently signed partnership with Sanofi (SNY) to market its COVID-19 vaccine and develop novel COVID-19-influenza combination vaccines.
Here is how Boston Scientific (BSX) and Novavax (NVAX) have performed compared to their sector so far this year.